Cabot (CBT)
(Delayed Data from NYSE)
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
Cabot (CBT) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 10.34% and 0.58%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Eastman Chemical, Cabot and Kronos Worldwide
by Zacks Equity Research
Eastman Chemical, Cabot and Kronos Worldwide have been highlighted in this Industry Outlook article.
3 Diversified Chemical Stocks to Escape Industry Headwinds
by Anindya Barman
Demand softness in specific markets, de-stocking and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. EMN, CBT and KRO are poised to navigate the industry challenges.
Zacks.com featured highlights include Walmart, Agnico Eagle, Booz Allen Hamilton, Vertiv and Cabot
by Zacks Equity Research
Walmart, Agnico Eagle, Booz Allen Hamilton, Vertiv and Cabot have been highlighted in this Screen of The Week article.
Why Cabot (CBT) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
5 Stocks That Boast Solid History of Dividend Growth
by Sweta Killa
Walmart (WMT), Agnico Eagle (AEM), Booz Allen Hamilton (BAH), Vertiv Holdings (VRT) and Cabot (CBT) could be compelling picks given their history of dividend increase.
Should Value Investors Buy Cabot (CBT) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What Makes Kronos Worldwide (KRO) Stock a Solid Choice Right Now
by Zacks Equity Research
Kronos Worldwide (KRO) benefits from higher demand for TiO2, improved selling prices and its actions to reduce costs.
Here's Why You Should Hold Onto CF Industries (CF) Stock for Now
by Zacks Equity Research
While softer nitrogen prices weigh on CF Industries' (CF) sales and margins, it benefits from healthy global demand for nitrogen fertilizers and lower natural gas costs.
Why You Should Retain DuPont (DD) Stock in Your Portfolio
by Zacks Equity Research
While DuPont (DD) faces headwinds from soft demand in certain markets, it benefits from its focus on growth through innovation, the Spectrum Plastics acquisition and productivity actions.
Here's Why You Should Hold Onto Celanese (CE) Stock for Now
by Zacks Equity Research
Celanese (CE) benefits from its productivity measures, investments in organic projects, expansion actions and strategic acquisitions amid headwinds from demand softness and pricing pressures.
CBT vs. AIQUY: Which Stock Is the Better Value Option?
by Zacks Equity Research
CBT vs. AIQUY: Which Stock Is the Better Value Option?
Kronos Worldwide (KRO) Shares Rally 36% in 6 Months: Here's Why
by Zacks Equity Research
Kronos Worldwide (KRO) gains on higher demand for TiO2, improved pricing and its cost-reduction actions.
Do Options Traders Know Something About Cabot (CBT) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Cabot (CBT) stock based on the movements in the options market lately.
Zacks.com featured highlights include Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot
by Zacks Equity Research
Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot are part of the Zacks Screen of the Week article.
4 Stocks That Boast Remarkable Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. THC, LDOS, ATO and CBT are sound enough to meet financial obligations.
Zacks.com featured highlights include Leidos, Cabot, Williams-Sonoma, Booz Allen Hamilton and Brady
by Zacks Equity Research
Zacks.com featured highlights include Leidos, Cabot, Williams-Sonoma, Booz Allen Hamilton and Brady
5 Dividend Stocks to Pick for Solid Growth in the Second Half
by Sweta Killa
Leidos Holdings (LDOS), Cabot (CBT), Williams-Sonoma. (WSM), Booz Allen Hamilton (BAH) and Brady (BRC) could be compelling picks heading into the second half of the year.
CBT vs. AIQUY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CBT vs. AIQUY: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights DuPont de Nemours, Axalta Coating Systems, Cabot and Kronos Worldwide
by Zacks Equity Research
DuPont de Nemours, Axalta Coating Systems, Cabot and Kronos Worldwide are part the Zacks top Analyst Blog.
4 Top Chemical Stocks to Buy As Destocking Has Run Its Course
by Anindya Barman
A rebound in end-market demand, moderating raw material and energy costs and the absence of customer inventory de-stocking augur well for the chemical industry. DD, AXTA, CBT and KRO are worth a look.
Buy These 4 Stocks With Remarkable Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. THC, STRL, ATO and CBT are sound enough to meet financial obligations.
Why Cabot (CBT) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Has Cabot (CBT) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Cabot (CBT) and AngloGold Ashanti (AU) have performed compared to their sector so far this year.
Is Cabot (CBT) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.